[go: up one dir, main page]

DK1718675T3 - Fremgangsmåde til at tilvejebringe en oprenset virussikker antistoftilberedning - Google Patents

Fremgangsmåde til at tilvejebringe en oprenset virussikker antistoftilberedning

Info

Publication number
DK1718675T3
DK1718675T3 DK05716804.9T DK05716804T DK1718675T3 DK 1718675 T3 DK1718675 T3 DK 1718675T3 DK 05716804 T DK05716804 T DK 05716804T DK 1718675 T3 DK1718675 T3 DK 1718675T3
Authority
DK
Denmark
Prior art keywords
providing
antibody preparation
purified virus
safe antibody
safe
Prior art date
Application number
DK05716804.9T
Other languages
English (en)
Inventor
Andrea Buchacher
Guenther Iberer
Juergen Roemisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34910983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1718675(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1718675T3 publication Critical patent/DK1718675T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2103/05—

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK05716804.9T 2004-02-27 2005-02-25 Fremgangsmåde til at tilvejebringe en oprenset virussikker antistoftilberedning DK1718675T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54810704P 2004-02-27 2004-02-27
PCT/EP2005/050812 WO2005082937A2 (en) 2004-02-27 2005-02-25 A method of providing a purified, virus safe antibody preparation

Publications (1)

Publication Number Publication Date
DK1718675T3 true DK1718675T3 (da) 2013-07-15

Family

ID=34910983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05716804.9T DK1718675T3 (da) 2004-02-27 2005-02-25 Fremgangsmåde til at tilvejebringe en oprenset virussikker antistoftilberedning

Country Status (18)

Country Link
US (1) US7553938B2 (da)
EP (2) EP1718675B2 (da)
JP (1) JP5042817B2 (da)
KR (1) KR101206788B1 (da)
CN (1) CN1922207B (da)
AU (1) AU2005217148B2 (da)
BR (1) BRPI0508096B8 (da)
CA (1) CA2557229C (da)
DK (1) DK1718675T3 (da)
ES (1) ES2407380T5 (da)
IL (1) IL177541A (da)
NO (1) NO20063784L (da)
PL (1) PL1718675T3 (da)
PT (1) PT1718675E (da)
RU (1) RU2337109C2 (da)
UA (1) UA87836C2 (da)
WO (1) WO2005082937A2 (da)
ZA (1) ZA200607119B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009017491A1 (en) * 2006-06-14 2009-02-05 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
EP1958626B1 (en) 2007-02-13 2014-07-23 Ajinomoto Co., Inc. Method for inactivating viruses by addition of slightly acidic arginine
EP2271374B1 (en) * 2008-03-28 2014-03-05 Research Foundation For Medical Devices Method of viral inactivation of biological fluids by solvent/detergent-treatment
EP2762492A3 (en) 2009-05-27 2015-03-18 Baxter International Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
EP2519537A4 (en) * 2009-12-29 2013-07-10 Reddys Lab Ltd Dr CLEANING PROTEINS
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
EP2399613A1 (en) * 2010-06-22 2011-12-28 Research Foundation For Medical Devices Fractionation of plasma using caprylic acid
RU2610667C2 (ru) * 2010-10-11 2017-02-14 Эббви Бахамаз Лтд., Способ очистки белков
WO2012049245A1 (en) 2010-10-13 2012-04-19 Octapharma Ag Method for purification of complement factor h
TR201807926T4 (tr) 2011-02-04 2018-06-21 Octapharma Ag Koagülasyon faktörlerinin çökeltme yoluyla etkisizleştirilmesine/çıkarılmasına yönelik usul.
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
CN102286099B (zh) * 2011-08-05 2014-04-09 深圳市卫光生物制品股份有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
DK3590960T3 (da) 2012-02-29 2023-04-24 Takeda Pharmaceuticals Co Igg-stimuleret remyelinisering af perifere nerver
EP2855504B1 (en) * 2012-05-31 2018-10-24 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
CN102757496B (zh) * 2012-06-07 2014-06-18 山东泉港药业有限公司 一种抗vegf抗体片段的纯化制备方法
LT2864346T (lt) * 2012-06-21 2019-01-25 Synthon Biopharmaceuticals B.V. Antikūnų gryninimo metodas
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
SG11201505192RA (en) * 2013-02-28 2015-08-28 Agency Science Tech & Res Chromatographic purification of antibodies from chromatin-deficient cell culture harvests
CA2902854C (en) 2013-03-08 2024-01-23 Genzyme Corporation Integrated continuous manufacturing of therapeutic protein drug substances
SG11201506494XA (en) * 2013-03-15 2015-09-29 Glaxosmithkline Ip No 2 Ltd Methods for purifying antibodies
CN105745218B (zh) 2013-11-15 2020-11-06 诺华股份有限公司 去除残留细胞培养杂质
RU2561596C2 (ru) * 2013-12-18 2015-08-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ приготовления вирусинактивированных растворов иммуноглобулинов с низким остаточным содержанием каприловой кислоты
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
JP2017507149A (ja) * 2014-02-27 2017-03-16 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 抗体精製方法
CN106414476B (zh) * 2014-03-11 2019-12-31 株式会社绿十字控股 用于纯化免疫球蛋白的方法
CN106459142B (zh) * 2014-04-30 2021-07-13 诺和诺德股份有限公司 使用辛酸纯化蛋白质的方法
WO2015195452A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Single-pass filtration systems and processes
WO2015195453A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Methods for increasing the capacity of flow-through processes
SG10201908746UA (en) 2014-06-25 2019-10-30 Emd Millipore Corp Compact spiral-wound filter elements, modules and systems
KR102235952B1 (ko) 2014-08-29 2021-04-07 이엠디 밀리포어 코포레이션 잔류물의 재순환을 이용한 싱글 패스 접선 유동 여과 시스템 및 접선 유동 여과 시스템
KR102061553B1 (ko) 2014-08-29 2020-02-11 이엠디 밀리포어 코포레이션 잔류물의 재순환에 의한 싱글 패스 접선 유동 여과 시스템 및 접선 유동 여과 시스템을 사용하여 액체를 여과하는 공정
SI4209499T1 (sl) 2015-08-13 2025-01-31 Amgen Inc. Globinsko nabito filtriranje proteinov, ki vežejo antigen
PT3135687T (pt) 2015-08-31 2019-05-21 Inst Grifols S A Método para preparação de imunoglobulinas
CA3077712C (en) 2016-06-09 2022-03-22 Emd Millipore Corporation Radial-path filter elements, systems and methods of using same
EP3254671B1 (en) 2016-06-10 2019-11-13 Octapharma AG High concentration immunoglobulin composition for pharmaceutical application
IT201600079328A1 (it) * 2016-07-28 2018-01-28 Altergon Sa Metodo migliorato per la decontaminazione di materiale biologico mediante partizione e inattivazione
SG11201901059QA (en) 2016-09-07 2019-03-28 Glaxosmithkline Ip Dev Ltd Methods for purifying antibodies
RU2708394C2 (ru) * 2016-09-26 2019-12-06 Институто Грифольс,С.А. Способ получения иммуноглобулинов
JP6370853B2 (ja) * 2016-09-26 2018-08-08 インスティトゥト グリフォルス，ソシエダ アノニマ 免疫グロブリンの調製方法
WO2019219890A1 (en) 2018-05-17 2019-11-21 Csl Behring Ag Method and system of protein extraction
SG11202101860UA (en) 2018-08-31 2021-03-30 Genzyme Corp Sterile chromatography resin and use thereof in manufacturing processes
CN110627892B (zh) * 2019-09-05 2023-04-14 江苏康禾生物制药有限公司 一种重组人血小板生成因子原液的制备方法
CN110590931B (zh) * 2019-09-05 2023-04-07 江苏康禾生物制药有限公司 去除和/或灭活重组人血小板生成因子原液中病毒的方法
AU2021249040A1 (en) 2020-03-31 2022-09-15 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation from C-1 inhibitor depleted plasma
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法
JP7606185B2 (ja) * 2020-09-03 2024-12-25 日機装株式会社 フェノールレッド吸着剤およびフェノールレッドの除去方法
CA3203540A1 (en) * 2020-12-28 2022-07-07 Eugene ZURLO Systems and methods for process scale isolation of immunoglobulin g
IL308819A (en) * 2021-05-26 2024-01-01 Csl Behring Ag Separation of plasma components by continuous extraction
BE1029863B1 (nl) * 2022-05-10 2023-05-12 Prothya Biosolutions Belgium WERKWIJZEN VOOR HET PRODUCEREN VAN IMMUNOGLOBULINE G (IgG) PREPARATEN EN/OF OPLOSSINGEN
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU836831A1 (ru) * 1978-07-19 1982-04-23 Научно-исследовательский институт эпидемиологии и микробиологии Способ получени иммуноглобулинового препарата
CA1201063A (en) 1982-07-20 1986-02-25 Winnipeg Rh Institute Inc., (The) Process for preparing purified immune globulin (igg)
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8807380D0 (en) 1988-03-29 1988-05-05 Gunn A Blood processing apparatus
US4939176A (en) 1988-12-20 1990-07-03 Miles Inc. Viral inactivation process
DE4125625C2 (de) 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
WO1997003706A1 (fr) 1995-07-14 1997-02-06 Croix-Rouge De Belgique Procede et installation d'inactivation de contaminants presents dans des produits sanguins
US5808011A (en) 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
JP4685238B2 (ja) * 1998-06-09 2011-05-18 ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
CN1151174C (zh) * 1998-12-21 2004-05-26 蒋盘宏 抗人淋巴细胞球蛋白制备方法
EP1709077A1 (en) * 2004-01-30 2006-10-11 Suomen Punainen Risti Veripalvelu Process for the manufacture of virus safe immunoglobulin

Also Published As

Publication number Publication date
AU2005217148A1 (en) 2005-09-09
CA2557229C (en) 2012-07-10
WO2005082937A3 (en) 2005-11-17
BRPI0508096B1 (pt) 2019-04-02
ES2407380T5 (es) 2017-07-07
JP2007533660A (ja) 2007-11-22
ES2407380T3 (es) 2013-06-12
EP1718675B1 (en) 2013-04-10
UA87836C2 (ru) 2009-08-25
EP1718675B2 (en) 2017-01-25
BRPI0508096B8 (pt) 2021-05-25
IL177541A (en) 2014-09-30
CA2557229A1 (en) 2005-09-09
US20070173638A1 (en) 2007-07-26
WO2005082937A2 (en) 2005-09-09
CN1922207B (zh) 2012-06-06
EP1718675A2 (en) 2006-11-08
NO20063784L (no) 2006-09-25
US7553938B2 (en) 2009-06-30
PL1718675T3 (pl) 2013-09-30
JP5042817B2 (ja) 2012-10-03
ZA200607119B (en) 2007-04-25
KR101206788B1 (ko) 2012-11-30
KR20060131920A (ko) 2006-12-20
IL177541A0 (en) 2006-12-10
RU2337109C2 (ru) 2008-10-27
CN1922207A (zh) 2007-02-28
EP2277915A1 (en) 2011-01-26
RU2006134285A (ru) 2008-04-10
BRPI0508096A (pt) 2007-07-17
PT1718675E (pt) 2013-05-21
AU2005217148B2 (en) 2011-09-08

Similar Documents

Publication Publication Date Title
DK1718675T3 (da) Fremgangsmåde til at tilvejebringe en oprenset virussikker antistoftilberedning
NO2022026I1 (no) Secukinumab - forlenget SPC
CY2022001I2 (el) Παραγωγα του uk-2a
NO20071430L (no) Anti-OX4OL antistoffer
DK1748077T3 (da) Fremgangsmåde til fremstilling af protein
DK1737891T3 (da) Anti-p-selectin-antistoffer
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
EP1765396A4 (en) ANTIBODY
FI20055616L (fi) Menetelmä valmisteen rakenteen muokkaamiseen
DE602005018315D1 (de) Rollstuhl
DK1757820T3 (da) Fastgørelsesindretning for strukturelement
DK1942967T3 (da) Fremgangsmåde til dosering af medikamenter
NO20043305D0 (no) Preparation of lodixanol
DK1831605T3 (da) Fremgangsmåde vedrørende forbrænding
DE502005005664D1 (de) Chronograph
EP1761562A4 (en) CONFORMATION SPECIFIC ANTIBODIES
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DE112005001784A5 (de) Geruchsverschluss
DE602005000799D1 (de) Flanschstruktur
DK1727792T3 (da) Fremgangsmåde til fremstilling af semicarbazoner
FI20041380L (fi) Tehtävänsijoitusmenetelmä
FI20040145A0 (fi) Menetelmä virusturvallisen immunoglobuliinin valmistamiseksi
EP1712564A4 (en) MONOCLONAL ANTI-NC1 ANTIBODY
FI20045472A0 (fi) Tietokantasynkronointi